Literature DB >> 33571906

The differentiation of colorectal cancer is closely relevant to m6A modification.

Shuai Wang1, Xiaoyan Fan2, Jun Zhu1, Dong Xu3, Ruikai Li1, Rujie Chen1, Junbi Hu4, Yao Shen5, Jun Hao2, Ke Wang6, Xunliang Jiang6, Yaofeng Wang6, Yu Jiang7, Jipeng Li8, Jian Zhang9.   

Abstract

The occurrence and development of tumors cannot be separated from the influence of differentiation at different stages and levels. Our study found that E-cadherin was significantly increased in cell model induced by sodium butyrate and cell density, while METTL3, METTL16 and WTAP were decreased during the differentiation of cells. In the clinicopathological tissues, E-cadherin was low expressed in poorly differentiated tumor tissues and above three regulators were highly expressed in poorly differentiated tissues. At the levels of clinicopathological differentiation, tissue differentiation and cell differentiation, the result indicated that the poor prognosis of colorectal cancer (CRC) may be closely related to high expression of total m6A level and high expression of METTL3, METTL16 and WTAP.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Differentiation; E-cadherin; METTL3; WTAP

Year:  2021        PMID: 33571906     DOI: 10.1016/j.bbrc.2021.02.001

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

Review 1.  N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.

Authors:  Yiling Ge; Tong Liu; Chuntao Wang; Yanqiu Zhang; Siyi Xu; Yiyi Ren; Yanlu Feng; Lihong Yin; Yuepu Pu; Geyu Liang
Journal:  RNA Biol       Date:  2021-10-21       Impact factor: 4.766

2.  PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.

Authors:  Ying Wu; Zhe Wang; Lu Han; Zhihao Guo; Bohua Yan; Lili Guo; Huadong Zhao; Mengying Wei; Niuniu Hou; Jing Ye; Zhe Wang; Changhong Shi; Suling Liu; Ceshi Chen; Suning Chen; Ting Wang; Jun Yi; JianPing Zhou; Libo Yao; Wenxia Zhou; Rui Ling; Jian Zhang
Journal:  Mol Ther       Date:  2022-03-10       Impact factor: 12.910

3.  Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation.

Authors:  Xiao-Fang Dong; Yan Wang; Chih-Hsin Tang; Bi-Fei Huang; Zhang Du; Qian Wang; Jun-Kang Shao; Hua-Jun Lu; Chao-Qun Wang
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

4.  Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.

Authors:  Huihui Ji; Jian-An Zhang; Hejing Liu; Kehan Li; Zhi-Wei Wang; Xueqiong Zhu
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

Review 5.  Role of WTAP in Cancer: From Mechanisms to the Therapeutic Potential.

Authors:  Yongfei Fan; Xinwei Li; Huihui Sun; Zhaojia Gao; Zheng Zhu; Kai Yuan
Journal:  Biomolecules       Date:  2022-09-02

Review 6.  RNA methyltransferase METTL16: Targets and function.

Authors:  Emily R Satterwhite; Kyle D Mansfield
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-07-06       Impact factor: 9.349

Review 7.  The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer.

Authors:  Xinwei Xu; Jintu Huang; Dickson Kofi Wiredu Ocansey; Yuxuan Xia; Zihan Zhao; Zhiwei Xu; Yongmin Yan; Xu Zhang; Fei Mao
Journal:  J Inflamm Res       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.